Clinical trials of new medications for myasthenia gravis and Lambert-Eaton myasthenic syndrome, as well as a large multi-center patient oriented outcome study of newly-diagnosed patients with myasthenia.
Using electrodiagnostic techniques and neurologic examination measures to assess patients serially in clinical trials involving various nerve and muscles disorders.
Autoimmune neuromuscular disorders – particularly the evaluation and management of patients with myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and chronic inflammatory polyneuropathy (CIDP).
back to top
Last updated: 10/30/2024
The Trustees of the University of Pennsylvania